Dopamine Therapeutic Use

NewsGuard 100/100 Score

Dopamine is a vital neurotransmitter in the brain. It plays a role in several functions in the brain including movement, memory, pleasurable reward, behavior and cognition, attention, inhibition of prolactin production, sleep, mood and learning.

Excess and deficiency of this vital chemical is the cause of several disease conditions. Parkinson's disease and drug addiction are some of the examples of problems associated with abnormal dopamine levels.

Uses of dopamine are both in cardiovascular diseases as well as central nervous system diseases.

Dopamine in Parkinson’s disease

Dopamine in blood is unable to cross the blood-brain barrier to reach the brain. In Parkinson’s disease and dopa-responsive dystonia there is a deficiency of dopamine in specific areas of the brain like the basal ganglia.

Levodopa is a dopamine precursor. It enters the brain by crossing the blood-brain barrier. It is typically co-administered with an inhibitor of peripheral decarboxylation (DDC, dopa decarboxylase), such as carbidopa or benserazide. This additional drug prevents breakdown of the levodopa to dopamine in the peripheral blood and ensures that maximum amount reaches the brain.

There are several other dopamine agonists and inhibitors of alternative metabolic route for dopamine by catechol-O-methyl transferase that may be used for these diseases. These include entacapone and tolcapone.

Dopamine in cardiovascular diseases

When administered through an IV line, dopamine does not cross the blood brain. It acts on the heart by raising its contractility and blood pressure. This is useful in heart failure

The effects of intravenous dopamine are dose dependent. The dosages include:

  1. 2-5 μg/kg/min (low dose) - This dose leads to renal and mesentric vasodilation (via D1 receptors). This dilatation of blood vessels of kidney leads to raised glomerular filtration rate and sodium excretion and raises urine output, leads to better tissue perfusion, BP stabilization. This dose is used in Cardiogenic shock as IV infusion.

  2. 5-10 μg/kg/min (moderate dose) - This dose also causes renal and mesentric vasodilation (via D1). This raises the GFR and sodium excretion and raises urine output, better tissue perfusion and BP stabilization. This dose also acts on Beta 1 receptors on heart and makes its contractions and pumping more forceful. This is used in Acute exacerbation of congestive heart failure as IV infusion.

  3. More than 20 μg/kg/min (high dose) - This leads to constriction of blood vessels via Alpha 1 receptors. This leads to decreased renal blood flow and decreased urine output.

Further Reading

Last Updated: Jun 21, 2023

Dr. Ananya Mandal

Written by

Dr. Ananya Mandal

Dr. Ananya Mandal is a doctor by profession, lecturer by vocation and a medical writer by passion. She specialized in Clinical Pharmacology after her bachelor's (MBBS). For her, health communication is not just writing complicated reviews for professionals but making medical knowledge understandable and available to the general public as well.


Please use one of the following formats to cite this article in your essay, paper or report:

  • APA

    Mandal, Ananya. (2023, June 21). Dopamine Therapeutic Use. News-Medical. Retrieved on May 20, 2024 from

  • MLA

    Mandal, Ananya. "Dopamine Therapeutic Use". News-Medical. 20 May 2024. <>.

  • Chicago

    Mandal, Ananya. "Dopamine Therapeutic Use". News-Medical. (accessed May 20, 2024).

  • Harvard

    Mandal, Ananya. 2023. Dopamine Therapeutic Use. News-Medical, viewed 20 May 2024,


  1. Sandeep N Sandeep N India says:

    It has been well-established that "Chronic inflammation removes motivation by reducing dopamine in the brain". People suffering from Auto-immune disorders like RA, Ankylosing Spondylosis almost always suffer from lack of motivation, purpose & chronic depression. This is a serious problem. How can Dopamine be administered therapeutically in such cases ?

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
Innovative levodopa infusion pump trial shows promise for reducing Parkinson's symptoms